Solta Fraxel re:fine

Non-Ablative Fractional · 1410nm fractional

Work at Solta? — one claim covers all 5 of your devices.
DiscontinuedBe the first to review

New Solta Fraxel re:fine pricing is not published; used and refurbished systems trade around $5k–$12k. Solta Fraxel re:fine holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.

What it's actually cleared for: 1410nm non-ablative fractional resurfacing (Fraxel SR family)

Last verified: August 6, 2026 · How we verify

New: |Used: $5k–$12kmarket estimate, no email required

Key facts
ManufacturerSolta
CompanyOwner: Bausch Health Companies Inc. (NYSE/TSX: BHC) (subsidiary, since 2014) · Distribution: direct
CategoryResurfacing, Tattoo & Vascular
Technology1410nm fractional
FDA statusFDA Cleared
New price rangeNot published
Used price range$5k–$12k
ConsumablesNot published
Launch year2009
Last verifiedAugust 6, 2026
Save device

Overview

Entry Fraxel, short-lived

FDA & regulatory status

Authorized via 510(k)

What it's actually cleared for:

1410nm non-ablative fractional resurfacing (Fraxel SR family)

510(k) numbers

K050841; K062303; K063038

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Treatment economics

Economics data for this platform hasn't been published yet.

Chains using this device

No confirmed chain deployments recorded yet.

Owner reviews

Write a review

No verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.

Alternatives

Palomar StarLux (Lux1540/Lux2940)

Non-Ablative Fractional

Solta (Reliant) Fraxel SR750

Non-Ablative Fractional

Solta Clear + Brilliant Touch

Non-Ablative Fractional · $50k–$70k

Lutronic LaseMD Ultra

Non-Ablative Fractional · $60k–$90k

History

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. August 5, 2026

    FDA status

    UnknownCleared

    Source: Automatic record update

  2. August 5, 2026

    FDA K-numbers

    K050841; K062303; K063038

    Source: Automatic record update

  3. August 5, 2026

    FDA indication

    1410nm non-ablative fractional resurfacing (Fraxel SR family)

    Source: Automatic record update

  4. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Get the full State of Aesthetic Devices 2026 report

The first full census of the US aesthetic device market — preview it free.

Get the report